参考文献/References:
［1］COTTREAU C M, DASHEVSKY I, ANDRADE S E, et al. Pregnancy-Associated Cancer: A U.S. Population-Based Study ［J］. Journal of Women's Health, 2019, 28(2): 250-257.
［2］MATHEWS T J, HAMILTON B E. Mean age of mothers is on the rise: United States, 2000-2014［J］. NCHS Data Brief, 2016, 1(232): 1-8.
［3］GENIN A S, LESIEUR B, GLIGOROV J, et al. Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? ［J］. Breast (Edinburgh, Scotland), 2012, 21(4): 550-555.
［4］PILEWSKIE M, GORODINSKY P, FOUGHT A, et al. Association between recency of last pregnancy and biologic subtype of breast cancer ［J］. Annals of Surgical Oncology, 2012, 19(4): 1167-1173.
［5］MURPHY C G, MALLAM D, STEIN S, et al. Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer ［J］. Cancer, 2012, 118(13): 3254-3259.
［6］CRIVELLARI D, MILITELLO L. Prognosis of women with primary breast cancer diagnosed during pregnancy ［J］. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2014, 32(3): 255-263.
［7］LITTON J K, WARNEKE C L, HAHN K M, et al. Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer ［J］. The Oncologist, 2013, 18(4): 369-376.
［8］BOTHA M H, RAJARAM S, KARUNARATNE K. Cancer in pregnancy ［J］. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 2018, 143(Suppl 2): 137-142.
［9］BECKER S. Breast cancer in pregnancy: A brief clinical review ［J］. Best Practice & Research Clinical Obstetrics & Gynaecology, 2016, 33(1): 79-85.
［10］GERSTL B, SULLIVAN E, IVES A, et al. Pregnancy outcomes after a breast cancer diagnosis: a systematic review and meta-analysis ［J］. Clinical Breast Cancer, 2018, 18(1): e 79-e 88.
［11］SHACHAR S S, GALLAGHER K, MCGUIRE K, et al. Multidisciplinary management of breast cancer during pregnancy ［J］. The Oncologist, 2017, 22(3): 324-334.
［12］王富文，傅少梅，金玉春，等．妊娠期乳腺癌临床诊治回顾性分析 ［J］．中华外科杂志，2018，56（2）：114-118．
［13］VASHI R, HOOLEY R, BUTLER R, et al. Breast imaging of the pregnant and lactating patient: physiologic changes and common benign entities ［J］. American Journal of Roentgenology, 2013, 200(2): 329-336.
［14］SHAKERIAN R, THOMSON B N, JUDSON R, et al. Radiation fear: Impact on compliance with trauma imaging guidelines in the pregnant patient ［J］. The Journal of Trauma and Acute Care Surgery, 2015, 78(1): 88-93.
［15］AMANT F, VAN C K, HALASKA M J, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older:an observational study ［J］. Lancet Oncology, 2012, 13(3): 256-264.
［16］CHEN Jun-ying, HUANG Yi-jie, ZHANG Liu-lu, et al. Comparison of oncoplastic breast-conserving surgery and breast-conserving surgery alone: a meta-analysis ［J］. Journal of Breast Cancer, 2018, 21(3): 321-329.
［17］ASANO S, HAYASHI N, EDAKUBO Shunsuke, et al. Successful perinatal management of a ruptured brain arteriovenous malformation in a pregnant patient by endovascular embolization followed by elective cesarean section: a single-case experience ［J］. JA clinical reports, 2016, 2(1): 21.
［18］朱文谋，涂刚，陶隆钦．14例妊娠期乳腺癌的诊疗体会及文献回顾 ［J］．癌症进展，2019，17（1）：99-102．
［19］MURTHY R K, THERIAULT R L, BARNETT C M, et al. Outcomes of children exposed in utero to chemotherapy for breast cancer ［J］. Breast Cancer Research : BCR, 2014, 16(6): 500.
［20］LOIBL S, HAN S N, VON MINCKWITZ G, et al. Treatment of breast cancer during pregnancy: an observational study ［J］. The Lancet Oncology, 2012, 13(9): 887-896.
［21］HAHN K M, JOHNSON P H, GORDON N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero ［J］. Cancer, 2006, 107(6): 1219-1226.
［22］ZAGOURI F, SERGENTANIS T N, CHRYSIKOS D, et al. Taxanes for breast cancer during pregnancy: a systematic review ［J］. Clinical Breast Cancer, 2013, 13(1): 16-23.
［23］ZAGOURI F, SERGENTANIS T N, CHRYSIKOS D, et al. Platinum derivatives during pregnancy in cervical cancer：a systematic review and meta-analysis ［J］. Obstetrics and Gynecology, 2013, 121(2): 337-343.
［24］BERVEILLER P, MIR O. Taxanes during pregnancy: probably safe, but still to be optimized ［J］. Oncology, 2012, 83(4): 239-240.
［25］SEKHON J S, NAIK N, BANSAL P, et al. Practical consensus recommendations for gestational breast cancer ［J］. South Asian Journal of Cancer, 2018, 7(2): 115-117.
［26］BONILLA L, BEN-AHARON I, VIDAL L, et al. Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials ［J］. Journal of the National Cancer Institute, 2010, 102(24): 1845-1854.
［27］LOIBL S, SCHMIDT A, GENTILINI O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients ［J］. JAMA oncology, 2015, 1(8): 1145-1153.
［28］ZARKAVELIS G, PETRAKIS D, FOTOPOULOS G, et al. Bone and soft tissue sarcomas during pregnancy: A narrative review of the literature ［J］. Journal of Advanced Research, 2016, 7(4): 581-587.
［29］KOREN G. Motherisk update. Is ondansetron safe for use during pregnancy? ［J］. Canadian Family Physician Medecin de Famille Canadien, 2012, 58(10): 1092-1093.
［30］AMANT F, HALASKA M J, FUMAGALLI M A, et al. Gynecologic cancers in pregnancy guidelines of a second international consensus meeting ［J］. International Journal of Gynecological Cancer, 2014, 24(3): 394-403.
［31］GILBOA S M, AILES E C, RAI R P, et al. Antihistamines and birth defects: a systematic review of the literature ［J］. Expert Opinion on Drug Safety, 2014, 13(12): 1667-1698.
［32］CARDONICK E, IRFAN F, TORRES N. The use of neupogen(filgrastim)or neulasta(pegfilgrastim)during pregnancy when chemotherapy is indicated for maternal cancer treatment ［J］. Journal of Cancer Therapy, 2012, 3(2): 157-161.
［33］GOTTSCHALK I, BERG C, HARBECK N, et al. Fetal renal insufficiency following trastuzumab treatment for breast cancer in pregnancy: case report und review of the current literature ［J］. Breast Care (Basel, Switzerland), 2011, 6(6): 475-478.
［34］LAMBERTINI M, PECCATORI F A, AZIM H A. Targeted agents for cancer treatment during pregnancy ［J］. Cancer Treatment Reviews, 2015, 41(4): 301-309.
［35］PARODI E, ALLUTO A, MOGGIO G, et al. Transient ventricular hypocinesia after in utero anthracyclines exposure: a case-report and review of the literature ［J］. The Journal of Maternal-fetal & Neonatal Medicine, 2012, 25(2): 189-192.
［36］安培，丁焱，王慧，等．妊娠期乳腺癌个案管理方案的制订及实践 ［J］．中华护理杂志，2018，53（4）：433-437．
相似文献/References:
[1]吴池华,刘锦平.妊娠哺乳期乳腺癌的临床问题[J].中国计划生育和妇产科,2009,(05):0.
WU Chi-hua,LIU Jin-ping The department of breast surgery,The academy of science · Sichuan provincal peoples hospital.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(12):0.
[2]夏晓梦,方小玲.妊娠期宫颈细胞学与阴道镜检查的特征与处理[J].中国计划生育和妇产科,2013,(01):0.
XIA Xiao-meng,FANG Xiao-ling*.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[3]谢文杰,林兰,欧霞,等.超声诊断技术在乳腺癌早期诊断中的应用[J].中国计划生育和妇产科,2013,(01):0.
XIE Wen-jie*,LIN Lan,OU Xia,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[4]方慧彬,杨建华,朱赟珊,等.宫腔镜子宫内膜切除术对服用他莫昔芬的绝经后乳腺癌术后患者子宫内膜增生的抑制作用[J].中国计划生育和妇产科,2013,(04):0.
FANG Hui-bin,YANG Jian-hua,ZHU Yun-shan * ..[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[5]李光辉,孔丽君,张为远,等.子痫前期的脂代谢[J].中国计划生育和妇产科,2014,(01):0.
LI Guang-hui,KONG Li-jun,ZHANG Wei-yuan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(12):0.
[6]姜志欣,吴玉璘.女性人乳头瘤病毒感染及相关肿瘤[J].中国计划生育和妇产科,2014,(07):0.
[7]陈彧,冯欣,杨华,等.妊娠期疾病常用中成药使用原则及禁忌[J].中国计划生育和妇产科,2015,(02):0.
[8]周慧梅,李威,朱兰,等.妊娠期急性阑尾炎诊治进展[J].中国计划生育和妇产科,2015,(02):0.
[9]崔淑娟,马艳芬.妊娠期心理压力与自然流产的关系[J].中国计划生育和妇产科,2015,(03):0.
CUI Shu-juan,MA Yan-fen,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(12):0.
[10]何书励,马良坤,刘俊涛,等.早产和营养[J].中国计划生育和妇产科,2015,(05):0.